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Vitamin E and b-carotene affect the immune function and might influence the predisposition of man to infections. To examine whether vitamin E
or b-carotene supplementation affects tuberculosis risk, we analysed data of the Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC)
Study, a randomised controlled trial which examined the effects of vitamin E (50 mg/d) and b-carotene (20 mg/d) on lung cancer. The trial
was conducted in the general community in Finland in 1985–93; the intervention lasted for 6·1 years (median). The ATBC Study cohort consists
of 29 023 males aged 50–69 years, smoking at baseline, with no tuberculosis diagnosis prior to randomisation. Vitamin E supplementation had no
overall effect on the incidence of tuberculosis (risk ratio (RR) ¼ 1·18; 95 % CI 0·87, 1·59) nor had b-carotene (RR ¼ 1·07; 95 % CI 0·80, 1·45).
Nevertheless, dietary vitamin C intake significantly modified the vitamin E effect. Among participants who obtained 90 mg/d or more of vitamin C
in foods (n 13 502), vitamin E supplementation increased tuberculosis risk by 72 (95 % CI 4, 185)%. This effect was restricted to participants who
smoked heavily. Finally, in participants not supplemented with vitamin E, dietary vitamin C had a negative association with tuberculosis risk so
that the adjusted risk was 60 (95 % CI 16, 81) % lower in the highest intake quartile compared with the lowest. Our finding that vitamin E seemed
to transiently increase the risk of tuberculosis in those who smoked heavily and had high dietary vitamin C intake should increase caution towards
vitamin E supplementation for improving the immune system.
Adverse effects: Antioxidants: b-Carotene: Cohort studies: Randomised controlled trials
Vitamin E is extensively used as a nutrient supplement, for
example, approximately 25 % of the US population aged 60
or more used vitamin E supplements according to a recent
survey(1). Such a high proportion of people taking vitamin E
supplements makes the health effects of supplementation an
important public health issue and raises the question of
whether the effects are beneficial or not.
Many animal studies found that vitamin E increases resist-
ance to various bacterial and viral infections(2); however,
vitamin E shortened the survival of mice with malaria(3,4)
and increased the multiplication of Leichmania parasites
in hamsters(5). Some human studies reported an apparent
benefit of vitamin E on the immune system, such as an
increase in the delayed type hypersensitivity responses(6),
whereas some other studies found no effects(2,7,8). More-
over, three studies reported reduced bactericidal activity
of phagocytes in subjects administered large doses of
vitamin E(9 – 11).
Only a few trials in man have examined the effect of vita-
min E supplementation on clinical infectious disease out-
comes, mainly respiratory tract infections(12 – 18). On the
whole, these trials found no consistent benefit from vitamin
E. Paradoxically, one trial found an increase in the severity
of acute respiratory infections with 200 mg/d vitamin E(13).
In our previous analyses of the Alpha-Tocopherol, Beta-Caro-
tene Cancer Prevention (ATBC) Study cohort, we found no
net effect on the incidence of the common cold or pneumonia
with 50 mg/d vitamin E; however, in both cases we found
significant divergence in vitamin E effect so that certain par-
ticipants obtained benefit while some others suffered harm
from supplementation(16 – 18).
Available studies suggest that also b-carotene influences
the immune system(7,8). However, we found no effect of
20 mg/d b-carotene on the incidence of the common cold
and pneumonia in male smokers(15,17,18). In addition, no
effect on the incidence of respiratory and urinary tract infec-
tion was found in elderly patients treated with the combi-
nation of 6 mg/d b-carotene, 15 mg/d vitamin E and
120 mg/d vitamin C(19).
The present paper presents the effects of 6-year supplemen-
tation with vitamin E or b-carotene on the incidence of hospi-
tal-treated tuberculosis in the ATBC Study cohort, a large,
randomised, double-blind, placebo-controlled trial testing pri-
mary prevention of lung cancer. Previously we analysed the
relationship between dietary vitamin C intake and the inci-
dence of tuberculosis in the same cohort(20).
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The rationale, design and methods of the ATBC Study
examining the effects of vitamin E (DL-a-tocopheryl acetate,
50 mg/d) and b-carotene (20 mg/d) on the incidence of lung
cancer and other cancers have been described in detail else-
where(20 – 22). To be eligible, male participants living in
Finland, aged 50–69 years, had to smoke five or more ciga-
rettes per day at entry, and those enrolled to the trial
(n 29 133) were randomised to one of four intervention
groups and administered placebo (n 7287), vitamin E
(n 7286), b-carotene (n 7282) or vitamin E þ b-carotene
(n 7278), using a 2 £ 2 factorial design. The intervention con-
tinued for 5–8 years (median 6·1 years) until 30 April 1993.
Compliance with supplementation was high: some 90 % of
the participants took more than 90 % of their prescribed cap-
sules during their active participation in the trial; there were
no differences in capsule consumption among the intervention
groups(22). Compared with baseline levels, supplementation
increased serum a-tocopherol by 50 %, whereas serum b-car-
otene increased 15-fold(22). The trial was approved by the
review boards of the participating institutions and all partici-
pants gave written informed consent. For the present analysis,
we excluded participants who had had hospital-treated tuber-
culosis before randomisation (n 110), resulting in 29 023 par-
ticipants at study entry. ATBC Study is registered at
ClinicalTrials.gov with identifier NCT00342992 (http://
clinicaltrials.gov/ct/show/NCT00342992).
Baseline characteristics
At baseline prior to randomisation the men completed ques-
tionnaires on their medical and smoking histories and general
background characteristics. A detailed dietary history ques-
tionnaire was completed that provided data regarding daily
food consumption(23). The dietary intakes of vitamin E, b-car-
otene and vitamin C were calculated using the food compo-
sition database of the National Public Health Institute(24).
Vitamin C supplement usage was rare and the doses were
small, therefore we ignored supplement usage in the ana-
lyses(20). Dietary data were not available for 2009 participants
and we excluded these men from the subgroup analyses focus-
ing on diet. A chest X-ray was taken at baseline to exclude
existing lung cancer and repeated every 28 months to enhance
the ascertainment of lung cancer during the trial(22).
Outcome
The events for the present study, the first hospital-treated
tuberculosis between randomisation and 30 April 1993, were
ascertained from the National Hospital Discharge Register
using the unique personal identification number assigned to
all Finnish citizens for linkage. The Register covers inpatient
visits from all public and private hospitals in Finland. It uses
the codes of the International Statistical Classification of Dis-
eases, Injuries, and Causes of Death (ICD), the 8th edition
(ICD-8) was used to the end of 1986, and the 9th edition
(ICD-9) thereafter. Up to four diagnoses per each discharge
are recorded, the primary diagnosis and three secondary diag-
noses. The validity of the Finnish Hospital Discharge Register
was examined from a random sample of 2211 discharges(25).
The registered cause of hospitalisation was compared with
the medical records and in 94·4 % of the cases the same diag-
nosis was reached. In the category of infections the agreement
was 88 %, based on thirty-three discharge records. Among
infections, tuberculosis is particularly well defined and there-
fore the accuracy may be higher than the average.
For the present study, we defined tuberculosis by ICD-8 and
ICD-9 codes 010–018, and both primary and secondary diag-
noses were accepted. There were 174 cases of new tuberculo-
sis from 1985 to 30 April 1993. In 160 cases tuberculosis was
in the respiratory tract (ICD-8 and ICD-9 codes 010–012).
These included two cases of primary tuberculosis (010), 137
cases of pulmonary tuberculosis (011) and twenty-one cases
of tuberculosis elsewhere in the respiratory tract (012). In
fourteen cases tuberculosis was in other organs (013–018).
Statistical analyses
Follow-up time for each participant began from the day of ran-
domisation, and continued until the date of first hospital dis-
charge for tuberculosis, death or the end of the trial, 30
April 1993, whichever came first. The median follow-up
time of the participants in the present analysis was 6·1
years, and there was a total of 168 845 person-years of obser-
vation. Use of the Hospital Discharge Register allowed infor-
mation on tuberculosis to be obtained in all study participants
irrespective of whether they continued in or had dropped out
from the trial.
We estimated the effects of vitamin E and b-carotene sup-
plementation on tuberculosis incidence through proportional
hazards regression models. We calculated the risk ratio (RR)
and the 95 % CI of the RR using the PROC PHREG program
of the SAS package of programs (version 8.1; SAS Institute
Inc., Cary, NC, USA). The 2 £ 2 factorial design of the trial
permitted assessment of the effects of vitamin E and b-caro-
tene independently after confirming no statistical interaction
between the agents at the level P,0·05. Thus, we compared
one half of the trial participants administered vitamin E with
the other half not receiving vitamin E (the no-vitamin
E group). Similarly, we compared one half of the trial
participants administered b-carotene with the other half not
receiving b-carotene (the no-b-carotene group). As to supp-
lementation, we carried out the analyses following the inten-
tion-to-treat principle.
To test the statistical significance of interaction between
supplementation and potential modifying factors, we first
added the supplementation and the modifying factor to the
regression model. The statistical significance of the inter-
action was thereafter calculated from the change in 22 £
log(likelihood) when the interaction term for supplementation
and the modifying factor were added to the model.
The major vitamin C sources in the diet of the study partici-
pants were fruit, vegetables and berries, on average 58 % of
calculated dietary vitamin C originated from these foods.
The median vitamin C intake was 90 mg/d. The total intake
of fruit, vegetables and berries (FRUVEBE) was strongly
correlated with the calculated vitamin C intake (r 0·88).
To analyse the possible role of dietary compounds other
than vitamin C in these foods we calculated the res-
idual of FRUVEBE intake (FRUVEBE-RES) using linear

















regression to model FRUVEBE as a function of dietary
vitamin C as previously(20):
FRUVEBE-RES ðg=dÞ
¼ FRUVEBE ðg=dÞ2 2·47 £ vitamin C ðmg=dÞ þ 35·4 ðg=dÞ:
As designed, FRUVEBE-RES had no correlation with diet-
ary vitamin C. We assume that any other putative compound
that might interact with vitamin E supplementation has no per-
fect linear correlation with vitamin C and therefore variation
in other compounds remains as variation in FRUVEBE-RES
which was split at 0 g/d, close to median. High FRUVEBE-
RES (over zero) indicates that the participant with a given
vitamin C level consumes more than average amount of
fruit, vegetables and berries, whereas low FRUVEBE-RES
(below zero) indicates less than average intake of these food
classes. Dietary vitamin E and b-carotene levels were split
at rounded levels close to medians.
The interaction between vitamin E supplementation and
continuous dietary vitamin C intake was calculated by first
including the mean vitamin E supplement effect and
dietary vitamin C intake (as square root to decrease the
weight of distant points), adjusting for the number of ciga-
rettes smoked, BMI and FRUVEBE-RES as continuous vari-
ables and for categorised age (50–59 or 60–69 years), marital
status (married, never married, divorced, widowed) and resi-
dential neighbourhood (city/town or village/countryside) as
previously(20). Thereafter we added the interaction term
between vitamin E and vitamin C and calculated the P value
from the change in 22 £ log(likelihood). After we found
that dietary vitamin C has different trends in the vitamin E
groups, we calculated the RR estimates for the vitamin C
intake quartiles and tested the trend of tuberculosis risk over
vitamin C intake adjusting for the same variables as earlier.
We calculated the P value for trend from the Wald test. We
analysed the interaction between b-carotene supplementation
and dietary vitamin C intake in the same way.
The difference in tuberculosis incidence between FRU-
VEBE-RES below and above 0 g/d was adjusted with the
number of cigarettes smoked, BMI, age, marital status and
residential neighbourhood.
Nelson–Aalen cumulative hazard functions were con-
structed using STATA sts graph program, release 9 (Stata
Corp., College Station, TX, USA). Two-tailed P values were
used.
Results
The baseline characteristics of the ATBC Study participants
have been described earlier(17,20), and the subgroup analyses
of Table 1 show the distribution of major characteristics.
During 168 845 person-years of follow-up of the study partici-
pants there were 174 new cases of hospital-diagnosed tubercu-
losis, representing a mean incidence rate of 103 cases per 105
person-years of follow-up.
Supplementation with either vitamin E or b-carotene had no
overall impact on the incidence of tuberculosis (Table 1).
In subgroup analyses we found that the effect of vitamin E
supplementation was significantly modified by dietary vitamin
C level so that vitamin E increased tuberculosis risk by 72 %
in those who obtained 90 mg/d or more of vitamin C in foods
(Table 1). The main food sources for vitamin C are fruit, vege-
tables and berries and we tested the possibility that other com-
pounds in such foods might explain the interaction with
vitamin E. Using linear regression to model fruit, vegetable
and berry intake with dietary vitamin C intake as the explana-
tory variable, we calculated the residual intake of fruit, vege-
tables and berries. Vitamin E supplementation was not
harmful for those who had high fruit, vegetable and berry
residual intake (Table 1), indicating that the modification of
vitamin E effect was not explained by other compounds in
foods. The effect of vitamin E supplementation was not sig-
nificantly modified by other tested variables (Table 1), or by
the age of smoking initiation, BMI and residential neighbour-
hood (data not shown).
Because vitamin E supplementation and dichotomous
dietary vitamin C intake showed a significant interaction, we
analysed whether the association between continuous dietary
vitamin C intake and tuberculosis risk differs between
vitamin E and no-vitamin E participants, and we found signifi-
cant divergence (interaction P¼0·014). In the no-vitamin E
group, participants in the highest vitamin C quartile had
60 % lower adjusted risk of tuberculosis compared with the
lowest vitamin C intake quartile, whereas dietary vitamin C
intake and tuberculosis risk had no association in the vitamin
E-supplemented group (Table 2).
Heavy smoking was associated with a tendency of vitamin
E to increase the risk of tuberculosis (Table 1) and previously
smoking modified the effect of vitamin E on common cold and
pneumonia incidence(16,17). Therefore, we explored the combi-
nation of smoking and dietary vitamin C. The apparent harm
of vitamin E was restricted to those who smoked heavily at
baseline and consumed vitamin C in amounts over the
median (Table 3; Fig. 1). Nevertheless, the increased risk
caused by vitamin E supplementation in this subgroup was
restricted to a one-year period after the initiation of supp-
lementation (Fig. 1). In the first year, there were twelve
cases of tuberculosis in the vitamin E group but only two
cases in the no-vitamin E group (P¼0·007, Fisher’s exact
test). After the first year, the incidence of tuberculosis did
not significantly differ between vitamin E and no-vitamin E
groups, as shown by the similarity of the slopes in Fig. 1,
yet there were more cases in the vitamin E group (nineteen
v. twelve).
In our previous analysis(20), we found that in heavy smokers
with vitamin C intake over 90 mg/d, high residual fruit, vege-
table and berry intake was associated with a substantial
reduction in tuberculosis risk. However, the vitamin E and
no-vitamin E participants were combined in that study(20).
Because we found interaction between vitamins E and C in
the current study, we analysed whether the effect of high
residual fruit, vegetable and berry intake might differ between
the vitamin E and no-vitamin E groups in heavy smokers with
vitamin C intake over 90 mg/d. Compared with the low
residual fruit, vegetable and berry intake group, the high
residual group had adjusted RR ¼ 0·35 (95 % CI 0·15, 0·83)
in the vitamin E group, and adjusted RR ¼ 0·18 (95 % CI
0·04, 0·80) in the no-vitamin E group. Thus the lower risk
of tuberculosis in the high fruit, vegetable and berry residual
groups was not influenced by vitamin E supplementation.
b-Carotene supplementation did not interact with the
variables we studied (Table 1), and it did not modify the




























Vitamin E No vitamin E b-Carotene No b-carotene
Subgroup No. of cases Rate No. of cases Rate RR 95 % CI No. of cases Rate No. of cases Rate RR 95 % CI
All participants 29 023 94 111 80 95 1·18 0·87, 1·59 90 107 84 99 1·07 0·80, 1·45
Age at baseline (years)
50–59 19 643 51 88 47 80 1·10 0·74, 1·63 0·6 47 81 51 87 0·93 0·63, 1·39 0·3
60–69 9380 43 162 33 126 1·28 0·81, 2·02 43 162 33 126 1·28 0·81, 2·02
Cigarettes per d
5–19 10 513 26 86 26 85 1·01 0·58, 1·74 0·5 26 84 26 86 0·98 0·56, 1·68 0·6
$20 18 510 68 126 54 100 1·26 0·88, 1·80 64 120 58 107 1·12 0·79, 1·61
Dietary vitamin C (mg/d)†
, 90 13 512 43 110 49 125 0·88 0·58, 1·33 0·042 49 127 43 109 1·16 0·77, 1·75 0·5
$ 90 13 502 41 103 24 60 1·72 1·04, 2·85 31 78 34 86 0·91 0·55, 1·48
Residual of fruit, vegetable and berries (g/d)†
, 0 14 215 55 134 42 102 1·31 0·88, 1·96 0·3 52 126 45 110 1·15 0·77, 1·71 0·5
$ 0 12 799 29 77 31 82 0·95 0·57, 1·57 28 75 32 84 0·90 0·54, 1·49
Dietary vitamin E (mg/d)†
, 10 11 709 44 131 36 106 1·23 0·79, 1·92 0·7
$ 10 15 305 40 89 37 82 1·08 0·69, 1·69
Dietary b-carotene (mg/d)†
, 1·5 11 430 41 124 43 131 0·95 0·62, 1·46 0·5
$ 1·5 15 584 39 86 34 74 1·15 0·73, 1·83
RR, risk ratio.
* Rate is given as the number of tuberculosis cases per 100 000 person-years. RR was estimated using the proportional hazards regression model comparing participants who received vitamin E and those who did not, and participants
who received b-carotene and those who did not. No covariates were included in the model, because the comparison is between randomized groups. The sizes of all compared intervention groups are the same within 3 % accuracy.
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association between dietary vitamin C and tuberculosis risk
(P¼0·2).
Discussion
Vitamin E did not reduce tuberculosis risk in the ATBC Study
cohort. This finding along with our previous findings(15 – 17)
refute the proposal that vitamin E supplementation would
have wide-ranging benefits on the immune system and protect
against diverse infections in the aged people(7).
Vitamin E increased the risk of tuberculosis in participants
with high dietary vitamin C intake levels, but the harm was
restricted to those who were smoking heavily at baseline
(Table 3). In two earlier analyses of the ATBC Study
cohort, focusing on the common cold and pneumonia, we
found significant divergence in the effects of vitamin E so
that certain participants got benefit from supplementation,
whereas some others were harmed. The harms were restricted
to those who smoked heavily at baseline or had initiated
smoking at an early age(16,17). In this respect, the increase in
tuberculosis risk with vitamin E in heavy smokers is consistent
with our earlier findings.
Vitamin E supplementation caused a transient increase in
the incidence of tuberculosis in heavy smokers with high die-
tary vitamin C intake. Evidently, this temporary increase was
not caused by new infections in the ATBC participants, but
by the reactivation of old infectious foci. The ATBC Study
participants were mostly born in the 1920s and 1930s, and
in the 1930s about 80 % of the Finnish population were
infected by Mycobacterium tuberculosis (26). Mortality
caused by tuberculosis was high and Finland was sometimes
referred to as ‘the black area on the European tuberculosis
map’(26). Currently latent tuberculosis infections in the
Table 3. The effect of vitamin E supplementation on tuberculosis risk:
modification by smoking and dietary vitamin C intake (Alpha-Tocopherol
Beta-Carotene Cancer Prevention Study)
Dietary vitamin C (mg/d)
Cigarettes per d at baseline ,90 $90
5–19
RR* 1·04 0·99
95 % CI 0·50, 2·19 0·41, 2·37
Cases of tuberculosis† 14/14 10/10
No. of participants 4439 5330
$20
RR* 0·82 2·25
95 % CI 0·50, 1·33 1·19, 4·23
Cases of tuberculosis† 29/35 31/14
No. of participants 9073 8172
RR, risk ratio.
* Proportional hazards regression model comparing participants who received vita-
min E and those who did not. No covariates were included in the model, because
the comparison is between randomised groups. The sizes of the compared vita-
min E and no-vitamin E groups are the same with 4 % accuracy.
† A/B refers to A cases in vitamin E participants and B cases in no-vitamin E
participants.
Fig. 1. Vitamin E supplementation and tuberculosis risk in Alpha-Tocopherol
Beta-Carotene Cancer Prevention Study participants smoking twenty or
more cigarettes per d with dietary vitamin C intake $90 mg/d (n 8172). Nel-
son–Aalen cumulative hazard functions for vitamin E (A) and no-vitamin E
(B) groups are shown. Each step indicates one case of tuberculosis. The log-
rank test gives P¼0·010 for the difference between the two curves and the
Wilcoxon test, which puts greater weight on the early observations, gives
P¼0·005.
Table 2. The risk of tuberculosis by dietary vitamin C intake in vitamin E-supplemented and non-supplemented participants (Alpha-Tocopherol
Beta-Carotene Cancer Prevention Study)
Dietary vitamin C intake divided by quartiles
Quartile 1 Quartile 2 Quartile 3 Quartile 4 Test for trend P value
Median (mg/d) 52 78 103 148
Range (mg/d) 5–65 66–89 90–120 121–534
No-vitamin E participants
Cases of tuberculosis 30 19 14 10
Adjusted RR* 1·00 0·73 0·56 0·40 0·004
95 % CI Reference 0·41, 1·30 0·29, 1·06 0·19, 0·84
Vitamin E participants
Cases of tuberculosis 22 21 25 16
Adjusted RR* 1·00 1·03 1·31 0·90 0·6
95 % CI Reference 0·57, 1·89 0·73, 2·35 0·46, 1·74
RR, risk ratio.
* Proportional hazards regression model comparing vitamin C groups to the lowest vitamin C group. Adjusted for the number of cigarettes smoked, BMI, age, marital status,
residential neighbourhood and the residual of fruit, berry and vegetable intake. The number of participants in each of the eight groups varies between 3350 and 3404.

















young generations are rare in developed countries, but
globally some third of all people are infected by
M. tuberculosis (27). Thus, the harm we observed probably is
not of major concern in high-income countries, but might be
important in some of the developing countries, in which smok-
ing and latent tuberculosis are prevalent. Although vitamin E
doubled the risk of tuberculosis in the heavy smokers with
high dietary vitamin C intake, only a few participants caught
tuberculosis. In this respect the observed increase in tubercu-
losis risk should not be exaggerated.
A recent review concluded that vitamin E supplementation
is safe for most adults in amounts up to 1000 mg/d(28). How-
ever, a recent meta-analysis found that, starting from
150 mg/d, vitamin E supplementation seemed to increase mor-
tality(29) and the large HOPE-TOO trial found increases in
hospitalisation due to heart failure with 400 Iu/d vitamin
E(30). Furthermore, a Dutch trial with older people reported
more severe symptoms of respiratory infections in those admi-
nistered 200 mg/d vitamin E(13). Our analyses of the ATBC
Study cohort indicate that in restricted groups of people vita-
min E supplementation may be harmful at a lower dose,
50 mg/d (Table 3)(16,17). Still, the findings suggest that there
is biological heterogeneity between population groups, so
that people’s characteristics determine whether vitamin E
supplements cause net benefit or harm and in this respect
the dosage of vitamin E may be an issue secondary to the per-
sonal characteristics.
In a previous analysis of tuberculosis cases in the ATBC
Study cohort, we focused on the relation between dietary vita-
min C intake and the risk of tuberculosis(20). Vitamin E supp-
lementation had no overall impact on tuberculosis risk, which
then justified us to ignore vitamin E when focusing on dietary
vitamin C. In the current study, we found significant inter-
action between vitamins E and C: high dietary vitamin C
intake was associated with a lower tuberculosis risk in the
no-vitamin E participants, but no similar association was
seen in the vitamin E participants (Table 2). Furthermore,
this interaction between vitamins E and C was not explained
by other components of fruit, vegetables and berries. The
negative association between dietary vitamin C and tuberculo-
sis risk in the no-vitamin E participants is consistent with
several guinea pig studies reporting benefit of vitamin C
against tuberculosis(2).
The interaction between vitamins E and C is interesting as
the water-soluble antioxidant vitamin C regenerates the lipid-
soluble antioxidant vitamin E in vitro and in vivo (2,31,32), and
both of them influence the immune system(2,7,8). Smoking
causes oxidation of vitamin C as indicated by the increased
plasma levels of dehydroascorbate, the oxidised form of vita-
min C(33). Furthermore, smoking increases plasma a-toco-
pherol disappearance rate, which is normalised by vitamin C
supplementation(34), implying that smoking modifies the inter-
action between these two antioxidants. To our knowledge, the
present study is the first to show interaction between vitamins
C and E with a clinically relevant outcome. However, contrary
to the anticipations based on biochemical studies, we found
evidence to suggest that the combination of high dietary vita-
min C intake and vitamin E supplementation is harmful in
heavy smokers (Table 3; Fig. 1).
It has been proposed that b-carotene improves the immune
system(7,8), but it did not affect tuberculosis risk in the ATBC
Study population or in any subgroup that we studied. Earlier
studies found no indications that b-carotene would protect
against clinical infections(15,17 – 19). Furthermore, two large-
scale trials found that b-carotene supplementation increased
total mortality(21,35).
In conclusion, it has been proposed that vitamin E and
b-carotene supplementation might lead to wide-ranging ben-
efits on the immune system. The present study found that
neither of these two compounds increased resistance against
tuberculosis in middle-aged male smokers. In contrast, vita-
min E appeared to transiently increase the incidence of
tuberculosis in participants who smoked heavily and had
dietary vitamin C intake of 90 mg/d or over. Although
vitamin E may be beneficial in restricted population
groups(16 – 18), those groups are poorly defined so far. The
consumption of vitamin E supplements by the general popu-
lation should be discouraged because there is evidence of
harm for some people.
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